6 Recruiting Triple Negative Breast Cancer Phase 1 / Phase 2 Clinical Trials
Active phase 1 / phase 2 studies for triple negative breast cancer enrolling across the USA. Verify eligibility and contact site coordinators.
All Triple Negative Breast Cancer studiesPhase 1 / Phase 2 Studies for Triple Negative Breast Cancer
🔵 Active, Not Recruiting Phase1 / Phase2
Ribociclib and Bicalutamide in AR+ TNBC
📍 University of Illinois Cancer Center — Chicago, Illinois
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase1 / Phase2
Standard of Care Chemotherapy Plus Pembrolizumab for Breast Cancer
📍 Cedars-Sinai Medical Center — Los Angeles, California
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
A Study of Tetrathiomolybdate (TM) Plus Capecitabine
📍 Indiana University Simon Cancer Center — Indianapolis, Indiana
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
ProAgio in Combination With Gemcitabine in Patients With Metastatic Triple Negative Breast Cancer
📍 Emory University Winship Cancer Institute — Atlanta, Georgia
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
📍 Mayo Clinic Comprehensive Cancer Center — Phoenix, Arizona
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
A Study of Sacituzumab Govitecan Given at an Alternative Dose and Schedule in Participants With Advanced Triple-Negative Breast Cancer
📍 Los Angeles Cancer Network (LACN) - Good Sam — Los Angeles, California
View Study & Checklist ➔